X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (34) 34
female (23) 23
male (22) 22
oncology (17) 17
analysis (16) 16
apoptosis (16) 16
adult (15) 15
cancer (15) 15
middle aged (14) 14
pathology (12) 12
aged (11) 11
polymorphism, single nucleotide (9) 9
tumors (9) 9
apoptosis - drug effects (8) 8
chromosome aberrations (8) 8
cytogenetics (8) 8
genetics & heredity (8) 8
health aspects (8) 8
hepatocellular-carcinoma cells (8) 8
immunohistochemistry (8) 8
activation (7) 7
animals (7) 7
apoptosis - physiology (7) 7
cell line, tumor (7) 7
chemotherapeutic drugs (7) 7
expression (7) 7
receptors, tnf-related apoptosis-inducing ligand - metabolism (7) 7
research (7) 7
tnf-related apoptosis-inducing ligand - metabolism (7) 7
gastroenterology & hepatology (6) 6
liver neoplasms - pathology (6) 6
medical informatics (6) 6
meningioma (6) 6
nf-kappa-b (6) 6
trail (6) 6
antineoplastic agents - pharmacology (5) 5
apoptosis-inducing ligand (5) 5
boronic acids - pharmacology (5) 5
bortezomib (5) 5
brain neoplasms - genetics (5) 5
carcinoma, hepatocellular - drug therapy (5) 5
carcinoma, hepatocellular - pathology (5) 5
comparative genomic hybridization (5) 5
cytogenetic analysis (5) 5
human hepatocytes (5) 5
in situ hybridization, fluorescence (5) 5
liver (5) 5
liver neoplasms - drug therapy (5) 5
neoplasm staging (5) 5
niacinamide - analogs & derivatives (5) 5
pyrazines - pharmacology (5) 5
retrospective studies (5) 5
trail-induced apoptosis (5) 5
universities and colleges (5) 5
aberrations (4) 4
aged, 80 and over (4) 4
cancer-cells (4) 4
cell line (4) 4
cells, cultured (4) 4
chemotherapy (4) 4
chromosome banding (4) 4
clinical neurology (4) 4
death receptors (4) 4
efficacy (4) 4
genetic research (4) 4
hematology, oncology and palliative medicine (4) 4
hepatocellular carcinoma (4) 4
in-vivo (4) 4
inhibition (4) 4
karyotyping (4) 4
ligand trail (4) 4
liver cancer (4) 4
medical education (4) 4
neurosciences (4) 4
oncology, experimental (4) 4
prognosis (4) 4
resistance (4) 4
therapy (4) 4
uniparental disomy (4) 4
abridged index medicus (3) 3
astrocytoma (3) 3
astrocytoma - genetics (3) 3
biomedicine (3) 3
blotting, western (3) 3
brain neoplasms - pathology (3) 3
cancer research (3) 3
care and treatment (3) 3
caspase-8 (3) 3
death (3) 3
death domain (3) 3
diarrhea (3) 3
disease-free survival (3) 3
dose-response relationship, drug (3) 3
emergency medicine (3) 3
flow cytometry (3) 3
gene expression regulation, neoplastic (3) 3
genetic aspects (3) 3
gliomas (3) 3
hepatitis c virus (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gut, ISSN 0017-5749, 12/2019, Volume 68, Issue 12, pp. 2170 - 2178
ObjectiveScheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic... 
biliary endoscopy | endoscopic retrograde pancreatography | cholestatic liver diseases | biliary strictures | primary sclerosing cholangitis
Journal Article
Journal Article
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 02/2020, Volume 59, Issue 2, pp. 106 - 110
Epithelioid hemangioendotheliomas (EHE) of the liver are rare, low‐malignant vascular tumors whose molecular pathogenesis is incompletely understood. The... 
hepatic epithelioid hemangioendothelioma | next‐generation parallel sequencing (NGS)
Journal Article
Molecular Cell, ISSN 1097-2765, 12/2009, Volume 36, Issue 5, pp. 831 - 844
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2006, Volume 12, Issue 8, pp. 2640 - 2646
Purpose: Tumor necrosis factor-related apoptosis–inducing ligand (TRAIL/Apo2L) exhibits potent antitumor activity on systemic administration in nonhuman... 
apoptosis | TRAIL | primary human hepatocytes | chemotherapy | in-vivo | tumoricidal activity | monoclonal-antibody | hepatocellular-carcinoma cells | human hepatocytes | receptor | death | nf-kappa-b | family | apoptosis-inducing ligand | HEPATOCELLULAR-CARCINOMA CELLS | APOPTOSIS-INDUCING LIGAND | ONCOLOGY | HUMAN HEPATOCYTES | IN-VIVO | RECEPTOR | TUMORICIDAL ACTIVITY | MONOCLONAL-ANTIBODY | DEATH | NF-KAPPA-B | FAMILY | Immunohistochemistry | Apoptosis Regulatory Proteins - pharmacology | Apoptosis - drug effects | Gene Expression - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | GPI-Linked Proteins | Apoptosis - genetics | Deoxycytidine - pharmacology | Hepatocytes - metabolism | Receptors, TNF-Related Apoptosis-Inducing Ligand | Organoplatinum Compounds - pharmacology | Receptors, Tumor Necrosis Factor, Member 10c | Dose-Response Relationship, Drug | Tumor Necrosis Factor Decoy Receptors | Hepatocytes - cytology | TNF-Related Apoptosis-Inducing Ligand | Time Factors | Apoptosis Regulatory Proteins - genetics | Antineoplastic Agents - pharmacology | Hepatocytes - drug effects | Camptothecin - analogs & derivatives | Receptors, Tumor Necrosis Factor - genetics | Receptors, Tumor Necrosis Factor - metabolism | Cell Survival - drug effects | Membrane Glycoproteins - pharmacology | Cells, Cultured | Etoposide - pharmacology | Cisplatin - pharmacology | Recombinant Proteins - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Membrane Glycoproteins - genetics | Tumor Necrosis Factor-alpha - pharmacology | Cell Line, Tumor | Fluorouracil - pharmacology | Camptothecin - pharmacology | Deoxycytidine - analogs & derivatives
Journal Article
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 02/2018, Volume 16, Issue 2, pp. 211 - 213
Journal Article